Navigation Links
T cell immunotherapy: Promising results in children and adults with leukemia
Date:12/7/2013

pted the CLL treatment for use against a high-risk form of ALL. The most common childhood cancer and the most common childhood leukemia, ALL may also occur in adults, such as the five adult patients in the current trial.

"Although most adults with ALL respond to drug treatment, as many as half of them eventually relapse, putting the overall cure rate for the disease only around 40 percent," said David L. Porter, M.D., a professor of Medicine and director of Blood and Marrow Transplantation in Penn's Abramson Cancer Center, who leads the adult CLL and ALL trials along with Noelle Frey, M.D., an assistant professor of Medicine. "Once a patient relapses, treatments are often ineffective. Many of these patients are not even eligible for bone marrow transplants, so this approach stands to give them an option where they would otherwise have had none."

As the CTL019 cells potently attacked leukemia cells, they also stimulated an unwanted, toxic immune response called cytokine release syndrome. The care team successfully counteracted these side effects with two immunomodulating drugs. In addition, because the CTL019 therapy eliminates healthy B cells along with cancerous B cells, patients must receive infusions of immunoglobin to perform the immune function provided by normal B cells.

"The results from the ALL and CLL trials also demonstrate that these engineered hunter cells greatly expand in patients, producing very high complete response rates, and then persist in patients, potentially allowing for long-term disease control. We are looking forward to testing these cells in upcoming multicenter pediatric and adult trials," said Grupp.


'/>"/>

Contact: Rachel Salis-Silverman
Salis@email.chop.edu
267-970-3685
Children's Hospital of Philadelphia
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. International gene therapy trial for bubble boy disease shows promising early results
2. Newly identified proteins make promising targets for blocking graft-vs.-host disease
3. Mouse studies reveal promising vitamin D-based treatment for MS
4. Mechanism offers promising new approach for harnessing the immune system to fight cancer
5. Scientists identify promising antiviral compounds
6. Horizon Pharma Abstract Prizes recognize promising fellows and students
7. Testing method promising for spinal cord injuries, multiple sclerosis
8. Large animal models of Huntingtons disease offer new and promising research options
9. Discovery could increase efficacy of promising cystic fibrosis drug
10. Sanford-Burnham and 60° Pharmaceuticals to pursue promising target for the treatment of dengue fever
11. Research finds promising approaches to prevent Latino childhood obesity
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
T cell immunotherapy: Promising results in children and adults with leukemia
(Date:11/4/2014)... Nov. 5, 2014 – University of Utah engineers developed ... help jet fuel produce electricity without needing to ignite ... to power portable electronics, off-grid power and sensors. , ... in the American Chemical Society journal ACS Catalysis ... a chemical reaction between a fuel and an oxygen-rich ...
(Date:11/4/2014)... Think about the way our bodies are assembled during ... that they are supposed to become a nerve or ... the correct place and alignment? Researchers at the University ... In a new study, UM researchers describe the signaling ... neighbors, at the head-trunk region. Their discovery may have ...
(Date:11/4/2014)... HOUSTON – (Nov. 4, 2014) – A majority of ... and that could have serious consequences for the rainforests ... researchers shows the positive impacts lemurs can have on ... impact their disappearance could have on the region,s rich ... rainforest have fruits eaten by lemurs. Lemurs in ...
Breaking Biology News(10 mins):Jet-fueled electricity at room temperature 2The inside story: How the brain and skull stay together 2Gardeners of Madagascar rainforest at risk 2Gardeners of Madagascar rainforest at risk 3
... Alberta researcher has discovered a rare practice by red squirrels ... its heart is also a survival tactic. U ... when he discovered a female had adopted a newborn squirrel ... candidate in evolutionary biology, found a baby red squirrel had ...
... funded by the U.S. economic stimulus program (ARRA) Health ... to advance the use of health information technology (HIT) ... been awarded to leading members of the American Medical ... the last two decades has advocated for informatics as ...
... and Space Sciences More than 2,200 scientists are ... sciences in Foz do Iguau at the 2010 Meeting of ... 8 to 12 August, are planning 377 scientific sessions on ... weather events in the Americas, climate impacts of megacities, greenhouse ...
Cached Biology News:Red squirrels: Altruists or self-serving survivalists? 2AMIA Members Manage HITECH Stimulus Grant Awards 22010 Meeting of the Americas, Brazil: News media registration open 22010 Meeting of the Americas, Brazil: News media registration open 32010 Meeting of the Americas, Brazil: News media registration open 4
(Date:11/22/2014)... During his lifetime Richard L. Sharp ... surround himself with great people and take risks to ... often marveled at his extraordinarily courageous attitude when taking ... -- even with his death impending—that’s how he continued ... would ultimately take his life. , Carrying on Sharp’s ...
(Date:11/22/2014)... Colo. (PRWEB) November 21, 2014 ... proprietary cloud based analytics and scientific testing methodologies relating ... commitment for a $750,000 line of credit from an ... extremely pleased to have secured this commitment from one ... Executive Officer of CannLabs. “This capital will help accelerate ...
(Date:11/22/2014)... IL (PRWEB) November 21, 2014 On ... competitors at the 2014 Emerging Medical Technologies Summit in ... Innovator Awards. Widely regarded among Silicon Valley investors ... medical device innovation, the win also positions Briteseed ... MedTech Innovator competition in 2015 and compete with other ...
(Date:11/22/2014)... 22, 2014 Respiratory therapy students ... proper management of life-like respiratory ailments using the ... . Grand Rapids-based, Michigan Instruments Inc. developers of ... of the respiratory simulation units to the pro-gram, ... Valley and Muskegon Community College are collaborating to ...
Breaking Biology Technology:Sherry Sharp, Wife of CarMax Founder, Richard Sharp, Accepts Seat on Board of Cure Alzheimer’s Fund 2Sherry Sharp, Wife of CarMax Founder, Richard Sharp, Accepts Seat on Board of Cure Alzheimer’s Fund 3CannLabs Secures $750,000 Line Of Credit 2Insight Product Development Accelerator Member Wins MedTech Innovator Award Competition 2Insight Product Development Accelerator Member Wins MedTech Innovator Award Competition 3Michigan Instruments Donates Two Respiratory Simulation Training and Test Lung (TTL) Devices to Grand Valley State University 2Michigan Instruments Donates Two Respiratory Simulation Training and Test Lung (TTL) Devices to Grand Valley State University 3
... 2011 The Jackson Laboratory (JAX), Sackler School of Graduate ... have unveiled a new mammalian genetics track for Ph.D. students. ... both JAX and Tufts. Combining the faculty and resources of ... disease, and the faculty and resources at JAX, with its ...
... EAST BRUNSWICK, N.J., Jan. 7, 2011 Savient Pharmaceuticals, Inc. ... its business activities related to the U.S. launch and commercialization ... the treatment of chronic gout in adult patients refractory to ... track for the promotional launch of KRYSTEXXA in the first ...
... Biopharma, a biopharmaceutical company developing novel and biosuperior ... that the company has entered into a multi-year ... commercialization of novel peptide-based therapeutics. Under ... receive an upfront payment of an undisclosed amount, ...
Cached Biology Technology:The Jackson Laboratory and Tufts University Announce New Ph.D. Track in Mammalian Genetics 2The Jackson Laboratory and Tufts University Announce New Ph.D. Track in Mammalian Genetics 3Savient Pharmaceuticals Provides Business Update 2Savient Pharmaceuticals Provides Business Update 3Savient Pharmaceuticals Provides Business Update 4Savient Pharmaceuticals Provides Business Update 5Savient Pharmaceuticals Provides Business Update 6Sutro Biopharma Forges Partnership with Pfizer for Discovery, Development and Commercialization of Novel Peptide-Based Therapeutics 2
Mouse polyclonal antibody raised against a partial recombinant KCTD13. NCBI Entrez Gene ID = 253980...
... direct antibiotic-based selection system for recombinant identification. ... eliminating the need for costly color screening. ... to 100% accuracy in recombinant selection. pLivSelect ... colony picking. This cloning kit is ...
Alpha-2-antiplasmin precursor (Alpha-2-plasmin inhibitor) (Alpha-2-PI) (Alpha-2-AP). [Source:Uniprot/SWISSPROT;Acc:P08697] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Mouse monoclonal antibody raised against a partial recombinant ZNF167. NCBI Entrez Gene ID = ZNF167...
Biology Products: